Literature DB >> 2545764

Pituitary-adrenal responses to CRH and insulin hypoglycemia in patients with idiopathic GH deficiency.

A Sartorio1, F Morabito, B Ambrosi.   

Abstract

It is well known that the activation of the hypothalamus-pituitary-adrenal axis (HPA) by insulin-induced hypoglycemia (IIH) is more potent and multifactorial than that caused by CRH administration. In this study we compared the clinical value of both tests in assessing the integrity of the HPA system. Plasma ACTH and cortisol responses to oCRH (1 microgram/kg iv) and IIH (insulin 0.1 U/kg iv, glycemia less than 40 mg/dl) were compared in 15 patients with idiopathic GH deficiency. The CRH-induced mean ACTH response was lower, but not significantly, in patients than in controls (peak: 8.8 +/- 1.7 vs 13.4 +/- 2.2 pmol/l), while the mean cortisol response was significantly lower than in normals (peak: 585.7 +/- 49.5 vs 764.5 +/- 52.2 nmol/l, p less than 0.005). Plasma ACTH and cortisol responses to IIH were significantly lower than in normal subjects (peak: 22.3 +/- 5.3 vs 35.8 +/- 5.2 pmol/l, p less than 0.05 and peak: 566.5 +/- 55 vs 803 +/- 38.5 nmol/l, p less than 0.02, respectively). Both in controls and in patients the CRH-induced mean ACTH response was significantly lower (p less than 0.02) than that after insulin, while cortisol peaks were not different. In conclusion, in patients with GH deficiency the impairment of ACTH secretion is not evident in basal condition, but it is disclosed after appropriate dynamic tests. It is confirmed that insulin hypoglycemia is a more potent stimulus than CRH for ACTH release.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545764     DOI: 10.1007/BF03349908

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin.

Authors:  E A Linton; F J Tilders; S Hodgkinson; F Berkenbosch; I Vermes; P J Lowry
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

2.  Corticotropin releasing factor (CRF): diagnostic implications.

Authors:  O A Müller; G K Stalla; J Hartwimmer; J Schopohl; K von Werder
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

3.  Beta-adrenergic mechanism of insulin-induced adrenocorticotropin release from the anterior pituitary.

Authors:  E Mezey; T D Reisine; M J Brownstein; M Palkovits; J Axelrod
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

4.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin.

Authors:  C Rivier; W Vale
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

5.  Evaluation of hypothalamic dysfunction in growth hormone (GH)-deficient patients using single versus multiple doses of GH-releasing hormone (GHRH-44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH-deficient patients.

Authors:  E A Schriock; J A Hulse; D A Harris; S L Kaplan; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

6.  Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.

Authors:  G S DeCherney; C R DeBold; R V Jackson; W R Sheldon; T C Kamilaris; D P Island; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

7.  Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.

Authors:  N Lytras; A Grossman; L Perry; S Tomlin; J A Wass; D H Coy; A V Schally; L H Rees; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1984-01       Impact factor: 3.478

8.  Oxytocin as well as vasopressin potentiate ovine CRF in vitro.

Authors:  F A Antoni; M C Holmes; M T Jones
Journal:  Peptides       Date:  1983 Jul-Aug       Impact factor: 3.750

9.  Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis.

Authors:  O A Müller; H G Dörr; B Hagen; G K Stalla; K von Werder
Journal:  Klin Wochenschr       Date:  1982-12-15

10.  Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.

Authors:  K Takano; N Hizuka; K Shizume; N Honda; N C Ling
Journal:  Acta Endocrinol (Copenh)       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.